Katarina Majercakova, MD (she/her/hers)

Radiation Oncologist
Hospital de la Santa Creu i Sant Pau, Spain

Between 2014-2016, while I was working at University Hospital Vienna/Medical University of Vienna, my research was focused on gynaecological tumors. Since 2016, when I started to work at Hospital de la Santa Creu i Sant Pau in Barcelona (acredited as reference center CSUR by Health Ministery and also taking a part in EURACAN), my main interest is in sarcomas, gynaecogical tumors and head and neck cancer.
I am an active member of national and international cooperative groups: GEIS (Spanish Research group in Sarcomas), FOSTER (Fight Osteosarcoma through European research), EURACAN, SEOR (Sociedad española de Oncología Radioterápica), ESTRO (European Society of Therapeutic Radiology and Oncology), GEC-ESTRO (The Groupe Européen de Curiethérapie (GEC) and the European SocieTy for Radiotherapy & Oncology).

Poster(s):

• (P 175) TRABECTEDIN PLUS RADIOTHERAPY ON SYMPHTOMATIC ADVANCED SARCOMA PATIENTS, RESULTS FROM THE SYNERGIAS STUDY: A SPANISH GROUP FOR RESEARCH IN SARCOMA (GEIS) PHASE II STUDY

• (P 313) SPACIALLY-FRACTIONATED RADIOTHERAPY (LATTICE) TREATMENT IN INOPERABLE NON-EXTREMITY BULKY SOFT-TISSUE SARCOMAS

• (P 503) SCAPULAR PROSTHESIS RECONSTRUCTION, EXPERIENCE IN OUR INSTITUTION

• (P 504) WHY DO SOME PATIENTS WITH SYNOVIAL SARCOMA HAVE BETTER FUNCTIONAL OUTCOMES AFTER RESECTION SURGERY? ANALYSIS OF 102 CASES

• (P 507) PRIMARY CHEST WALL TUMORS OF MESENCHYMAL ORIGIN. EXPERIENCE OF A REFERENCE UNIT

• (P 508) DREAM, UTOPIA OR REALISM? PROGNOSTIC FACTORS IN LUNG METASTASECTOMY OF DISSEMINATED SARCOMA DISEASE